China Health Management Corp.

About China Health Management Corp.

China Health Management Corp. operates as a healthcare and management company in China. It focuses on the operation and management of hospitals. The company provides healthcare services in the areas of gynaecology and obstetrics, paediatrics, stomatology, dermatology, medical cosmetology, pathology, ophthalmology and otolaryngology, anesthesia, and haemodialysis. Its services also include surgery, emergency medicine, intensive care, preventive medicine, pharmacy, psychological consultation therapy, medical consultation, combined Chinese and Western medicine, medical examination, medical imaging, medical functions examination, commissioning hospital management, hospital management consultation, etc. The company was formerly known as Max Internet Communications, Inc. and changed its name to China Health Management Corp. in March 2006. China Health Management Corp. was incorporated in 1996 and is based in Dallas, Texas.

Healthcare management company focused on Operations and Management of hospitals in China.

CNHC United States

0.0111USD0.0001 (+0.99%)

• At close Fri Oct 07 2022

Other OTC exchange

Sector: Financial Services

Industry: Shell Companies

Location United States, Dallas

Grade: AFA

660,527 USD
BETA (5y)


for 5 years
for 3 years
for 2 years
for last year
for this year
China Health Management Corp.
© 2023 All rights reserved
Make with 🤎 and ☕ for you!

Investing involves risk, including possible loss of principal.

The strategies discussed are strictly for illustrative and educational purposes and are not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. There is no guarantee that any strategies discussed will be effective.

International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation and the possibility of substantial volatility due to adverse political, economic or other developments. These risks often are heightened for investments in emerging/ developing markets or in concentrations of single countries.